Using 99mTc-labelled SM3 for Breast Cancer Evaluation
Author Information
Author(s): L Biassoni, M Granowska, MJ Carroll, SJ Mather, R Howell, D Ellison, FA MacNeill, CA Wells, R Carpenter, KE Britton
Primary Institution: St Bartholomew's Hospital, The Royal Hospitals NHS Trust, London, UK
Hypothesis
Can technetium-99m-labelled SM3 effectively evaluate axillary lymph node involvement in breast cancer patients?
Conclusion
The study found that the 99mTc SM3 technique accurately identified lymph node involvement in breast cancer patients, suggesting it could help tailor surgical approaches.
Supporting Evidence
- Sensitivity was 90% and specificity was 84% for detecting lymph node involvement.
- The technique showed a significant improvement in identifying node involvement compared to traditional methods.
- Imaging results were compared with clinical and histopathological data for accuracy.
Takeaway
Doctors used a special imaging technique to see if breast cancer had spread to lymph nodes, and it worked really well for most patients.
Methodology
The study involved 29 women with breast cancer who underwent radioimmunoscintigraphy using 99mTc SM3, with imaging at 10 minutes and 22 hours to assess lymph node involvement.
Potential Biases
Potential misregistration during imaging could lead to false positives.
Limitations
The study had a small sample size and some patients had previous surgeries that could affect results.
Participant Demographics
Women aged 34 to 84 years, median age 58.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website